Edward Lang
Corporate Officer/Principal bei GYROSCOPE THERAPEUTICS HOLDINGS PLC
Aktive Positionen von Edward Lang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Corporate Officer/Principal | 01.06.2019 | - |
Karriereverlauf von Edward Lang
Ehemalige bekannte Positionen von Edward Lang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01.12.2017 | 01.06.2018 |
Ausbildung von Edward Lang
| LaSalle University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 3 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Gyroscope Therapeutics Holdings Plc
 Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Gyroscope Therapeutics Holdings Plc engages in the development of gene therapy beyond rare diseases. It focuses on age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
- Börse
- Insiders
- Edward Lang
- Erfahrung
